文献速递脑血管病外科神经重症

Barrow破裂动脉瘤试验中脑室内出血的破裂动脉瘤患者第四脑室铸型的预后意义

The Prognostic Significance of a Cast Fourth Ventricle in Ruptured Aneurysm Patients With Intraventricular Hemorrhage in the Barrow Ruptured Aneurysm Trial (BRAT).
PubMed 文献 · Neurosurgery · 2019-01-01

本研究回顾Barrow破裂动脉瘤试验(BRAT)中238例动脉瘤性蛛网膜下腔出血(aSAH)合并脑室内出血(IVH)患者,影像学评估第四脑室铸型(CFV)对1年预后的影响。25例存在CFV,其入院格拉斯哥昏迷评分更低(7.8 vs 11.5,P<.001),出院及1年随访不良结局风险更高(P<.001和P=.002)。多因素分析中CFV预测1年不良预后(OR 6.4)强于Hunt-Hess分级>3级(OR 2.9,P<.001)。

要点

  • aSAH合并IVH患者中,CFV是1年不良结局的预测因素。
  • CFV患者入院GCS更低(7.8 vs 11.5,P<.001)。
  • 多因素分析CFV预测1年不良预后OR 6.4,强于Hunt-Hess>3级OR 2.9(P<.001)。

核心结论

  • CFV是aSAH患者不良结局的预测因素。
  • 与其他aSAH合并IVH患者相比,CFV预测不良结局强于不良Hunt-Hess分级。

研究设计与样本

  • 回顾性分析Barrow破裂动脉瘤试验(BRAT,NCT01593267)入组的406例患者,识别238例aSAH合并IVH患者,影像学评估CFV存在与否。
  • 结局于1年随访时评估,不良结局定义为改良Rankin量表评分>2。

主要发现

  • 25例患者存在CFV。
  • CFV患者入院格拉斯哥昏迷评分更低,7.8 vs 11.5(P<.001)。
  • 出院时和1年随访时,CFV患者不良结局风险更高(分别为P<.001和P=.002)。
  • 在79例IVH且初始格拉斯哥昏迷评分≤8分的患者亚组分析中,无CFV的IVH患者近50%获得良好恢复,而有CFV者仅7%(OR 15,P=.002)。
  • 多因素分析中,CFV预测aSAH后1年不良预后(OR 6.4)强于Hunt-Hess分级>3级(OR 2.9)(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ruptured aneurysms causing intraventricular hemorrhage (IVH) are associated with high morbidity. The presence of blood that completely fills the fourth ventricle (cast fourth ventricle, CFV) is thought to be particularly ominous, but studies documenting the outcome of such cases are lacking. OBJECTIVE: To investigate the outcomes of patients with aneurysmal subarachnoid hemorrhage (aSAH) and CFV. METHODS: We reviewed 406 patients enrolled in the Barrow Ruptured Aneurysm Trial (BRAT, NCT01593267, clinicaltrials.gov); 238 patients with aSAH and IVH were identified, and imaging was reviewed for the presence of CFV. Outcome was evaluated at the 1-yr follow-up. A poor outcome was defined as modified Rankin Scale score >2. RESULTS: CFV was identified in 25 patients. Admission Glasgow Coma Score was lower in CFV patients, 7.8 versus 11.5 (P < .001). At discharge and the 1-yr follow-up, patients with CFV had a greater risk of a poor outcome (P < .001 and P = .002, respectively). In a subgroup analysis of 79 patients with IVH and initial Glasgow Coma Score ≤ 8, almost 50% of the patients with IVH but without CFV had made a good recovery versus 7% of patients with CFV (odds ratio [OR] 15, P = .002). On multivariate analysis, CFV was a greater predictor of a poor prognosis at 1 yr post-aSAH than Hunt and Hess grade >3 (6.4 OR vs 2.9 OR [P < .001], respectively). CONCLUSION: The presence of CFV is a predictor of poor outcome in patients with aSAH. When compared to other patients with IVH and aSAH, CFV is a stronger predictor of a poor outcome than a poor Hunt and Hess Grade.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Catapano JS, Zabramski JM, Baranoski JF, et al. The Prognostic Significance of a Cast Fourth Ventricle in Ruptured Aneurysm Patients With Intraventricular Hemorrhage in the Barrow Ruptured Aneurysm Trial (BRAT). Neurosurgery. 2019. PMID: 30476225. doi:10.1093/neuros/nyy493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。